Results 221 to 230 of about 10,839,512 (369)
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
The impact of computer science education in primary schools: Evidence from a randomized controlled trial in Iraq. [PDF]
Shimizutani S, Taguchi S, Yamada H.
europepmc +1 more source
How-to conduct a systematic literature review: A quick guide for computer science research. [PDF]
Carrera-Rivera A+3 more
europepmc +1 more source
An ACM executive committee position on the crisis in experimental computer science [PDF]
Daniel D. McCracken+2 more
openalex +1 more source
Some computer science issues in ubiquitous computing
M. Weiser
semanticscholar +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source
Editorial: Advances in computer science and their impact on data acquisition and analysis in neuroscience. [PDF]
Koulen P+4 more
europepmc +1 more source
A first course in discrete structures with applications to computer science [PDF]
J. P. Tremblay, R. Manohar
openalex +1 more source
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen+12 more
wiley +1 more source